A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study

[1]  K. Hirata,et al.  Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture. , 2021, Journal of Parkinson's disease.

[2]  M. Costantini,et al.  Parkinson's disease patients' needs during the COVID‐19 pandemic in a red zone: A framework analysis of open‐ended survey questions , 2021, European journal of neurology.

[3]  J. Luciano,et al.  Impact of COVID-19 Lockdown Measures on Spanish People with Chronic Pain: An Online Study Survey , 2020, Journal of clinical medicine.

[4]  M. Rizzone,et al.  COVID-19 in Parkinson's disease: Report on prevalence and outcome , 2020, Parkinsonism & Related Disorders.

[5]  C. Tanner,et al.  The Impact of COVID‐19 on Access to Parkinson's Disease Medication , 2020, Movement disorders : official journal of the Movement Disorder Society.

[6]  R. Helmich,et al.  The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease , 2020, Journal of Parkinson's disease.

[7]  Z. Mari,et al.  Global Survey on Telemedicine Utilization for Movement Disorders During the COVID‐19 Pandemic , 2020, Movement disorders : official journal of the Movement Disorder Society.

[8]  A. Pisani,et al.  Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown , 2020, Movement disorders clinical practice.

[9]  O. Witte,et al.  Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson’s Disease in Germany , 2020, Journal of clinical medicine.

[10]  M. Etemadifar,et al.  Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID‐19) Pandemic , 2020, Movement disorders : official journal of the Movement Disorder Society.

[11]  P. Krack,et al.  Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience , 2020, Movement disorders clinical practice.

[12]  P. Pal,et al.  Parkinson's Disease and COVID‐19: Perceptions and Implications in Patients and Caregivers , 2020, Movement disorders : official journal of the Movement Disorder Society.

[13]  Carlo Colosimo,et al.  Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement Disorders , 2020, Movement disorders : official journal of the Movement Disorder Society.

[14]  R. Helmich,et al.  The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities , 2020, Journal of Parkinson's disease.

[15]  P. Scheltens,et al.  Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials , 2019, Journal of Neurology.

[16]  Silvio Lopes Alabarse,et al.  Physical Exercise Improves Quality of Life in Patients with Connective Tissue Disease , 2019, Connective Tissue Disease - Current State of the Art.

[17]  Samir Guglani.  Knowledge , 2016, The Lancet.

[18]  Marios Politis,et al.  Parkinson's disease symptoms: The patient's perspective , 2010, Movement disorders : official journal of the Movement Disorder Society.